Get started
Author

Fabienne Hartmann

Observed institution: Kantonsspital St. Gallen
ORCID: 0000-0003-2247-2693
Observed ORCID: 0000-0003-2247-2693
OpenAlex ID: A5059623729
Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer
2019 · Fiamma Berner, David Bomze, et al. · JAMA Oncology · 403
PDF
Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment
2021 · Sandra S. Ring, Jovana Cupovic, et al. · Nature Communications · 31
PDF
A replicating LCMV-based vaccine for the treatment of solid tumors
2023 · Mette-Triin Purde, Jovana Cupovic, et al. · Molecular Therapy · 6
PDF
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses
2020 · Sandra S. Ring, Michał Królik, et al. · Molecular Therapy — Oncolytics · 6
PDF
Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge
2021 · Michal Krolik, Lucia Csepregi, et al. · Vaccine · 4
Abstract 3298: Propagation competence of a self-antigen-targeting arenavirus vector based cancer therapy determines antitumor efficacy in mouse melanoma
2022 · Mette-Triin Purde, Fabienne Hartmann, et al. · Cancer Research
Works count: 6
Citation count: 450
H-index: 4
I10-index: 2
Year
Topic
Type